Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Allergy and Clinical Immunology|May 31, 2019
Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?Jorien van der Schaft, Judith L Thijs, Marjolein S de Bruin-Weller, et al.
Expert Opinion on Biological Therapy|February 16, 2019
Towards personalized treatment in atopic dermatitisJorien van der Schaft, Judith L Thijs, Floor M Garritsen, et al.
Acta Dermato-Venereologica|April 29, 2015
Serum creatinine levels during and after long-term treatment with cyclosporine A in patients with severe atopic dermatitisJorien van der Schaft, Arjan D van Zuilen, Joukje Deinum, et al.
Therapeutic Advances in Chronic Disease|September 6, 2018
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapyLieneke F M Ariëns, Daphne S Bakker, Jorien van der Schaft, et al.
Acta Dermato-Venereologica|May 11, 2019
Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic TreatmentLieneke F M Ariëns, Kirsten J M van Nimwegen, Marjan Shams, et al.
The Journal of Dermatological Treatment|March 13, 2018
Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugsDaphne S Bakker, Floor M Garritsen, Helen L Leavis, et al.
The Journal of Allergy and Clinical Immunology|June 12, 2020
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkersDaphne S Bakker, Stefan Nierkens, Edward F Knol, et al.
Acta Dermato-Venereologica|August 16, 2021
Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay RegistryLieneke F M Ariëns, Daphne S Bakker, Lotte S Spekhorst, et al.
Acta Dermato-Venereologica|February 21, 2017
Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive DrugsFloor M Garritsen, Jorien van der Schaft, Juul M van den Reek, et al.
Acta Dermato-Venereologica|March 18, 2016
Is There an Additional Value of Inpatient Treatment for Patients with Atopic Dermatitis?Jorien van der Schaft, Welmoed W Keijzer, Koos J G Sanders, et al.
Pageof 2